Thomas Jung, MD, PhD, has served as Auris Medical’s Chief Development Officer since September 2016 and leads the Company's clinical, preclinical and pharmaceutical development activities. Prior to joining Auris Medical, Dr. Jung served as the Chief Medical Officer at Delenex Therapeutics AG and spent 13 years at Novartis, most recently as Head, Translational Medicine for the European Union. He is a board-certified dermatologist and is an Associate Professor for Dermatology at the University of Göttingen, Germany.
Dermatology, pharmaceuticals